Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

NCT07360314 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

138

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: M7437
DRUG: M7437

Sponsor

EMD Serono Research & Development Institute, Inc.

Collaborators

[object Object]